Rebecca Nofsinger

发表

A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets

A. Bak, S. Bhardwaj, P. L. Walsh, 2016, Drug development and industrial pharmacy.

A comparison of the effects of p-glycoprotein inhibitors on the blood-brain barrier permeation of cyclic prodrugs of an opioid peptide (DADLE).

R. Borchardt, H. Ouyang, T. Andersen, 2009, Journal of pharmaceutical sciences.

Controlled release of etoricoxib from poly(ester urea) films for post-operative pain management.

M. Becker, R. Ji, T. Gustafson, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Comparing Dog and Human Intestinal Fluids: Implications on Solubility and Biopharmaceutical Risk Assessment

F. Kesisoglou, P. L. Walsh, W. Xu, 2016, AAPS PharmSciTech.

Discovery of MK‐8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption

Q. Dang, Jing Li, P. Coleman, 2015, ChemMedChem.

Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.

S. Clas, R. Sanchez, Rebecca Nofsinger, 2014, Drug discovery today.

3D printed capsules for quantitative regional absorption studies in the GI tract

Andre Hermans, Filippos Kesisoglou, F. Kesisoglou, 2018, International journal of pharmaceutics.

Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species.

Kung-I Feng, M. Altman, M. Cartwright, 2017, Molecular pharmaceutics.

A Retrospective Analysis of Preclinical and Clinical Pharmacokinetics from Administration of Long-Acting Aqueous Suspensions

Ashley R. Johnson, Xiaowei Zang, A. M. Wagner, 2023, Pharmaceutical Research.

Improving the Biopharmaceutical Properties of Cyclic Opioid Peptide Prodrugs

Rebecca Nofsinger, 2008 .

Assessing the Utility of In Vitro Screening Tools for Predicting Bio-Performance of Oral Peptide Delivery

Marian E. Gindy, Kung-I Feng, Scott E. Fauty, 2019, Pharmaceutical Research.

Design of Prodrugs to Enhance Colonic Absorption by Increasing Lipophilicity and Blocking Ionization

Q. Dang, P. Coleman, A. Templeton, 2014, Pharmaceuticals.

Factors that restrict the cell permeation of cyclic prodrugs of an opioid peptide, part 3: Synthesis of analogs designed to have improved stability to oxidative metabolism.

R. Borchardt, Rebecca Nofsinger, T. Fuchs-Knotts, 2012, Journal of pharmaceutical sciences.

Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical development.

Rebecca Nofsinger, Wenzhan Yang, Maya P. Lipert, 2023, Drug discovery today.

Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations.

F. Kesisoglou, Rebecca Nofsinger, Becky P Nissley, 2024, Molecular pharmaceutics.